Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | — | 13.5B | 14.1B | 13.5B |
| Cost of revenue | — | 10.7B | 11.1B | 10.6B |
| Gross profit | — | 2.8B | 3.0B | 2.9B |
| Operating expense | ||||
| Research & development | — | 397M | 392M | 413M |
| Selling general and admin | — | 1.5B | 1.4B | 1.4B |
| Other operating expenses | — | — | — | — |
| Operating income | — | 921M | 1.1B | 1.0B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | 141M | 147M | 149M |
| Other income expense | — | -76M | -115M | -32M |
| Pretax income | — | 704M | 862M | 827M |
| Tax provision | 100M | 139M | -44M | 187M |
| Net income | — | 565M | 906M | 640M |
| Basic EPS | — | 0.6 | 0.9 | 0.7 |
| Diluted EPS | — | 0.6 | 0.9 | 0.7 |
| Basic average shares | — | 948M | 959M | 979M |
| Diluted average shares | — | 957M | 971M | 990M |
| EBITDA | — | 1.1B | 1.4B | 1.3B |
| Net income from continuing op. | — | 565M | 906M | 640M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |